tiprankstipranks
Intellia Therapeutics Inc (NTLA)
NASDAQ:NTLA
US Market
NTLA
Intellia Therapeutics
RESEARCH TOOLSreports
Want to see NTLA full AI Analyst Report?

Intellia Therapeutics (NTLA) Stock News & Sentiment

4,835 Followers
Myles Minter Reiterates Buy on Intellia (NTLA), Citing Extended Cash Runway and Strong Phase III Data for Lonvoguran Ziclumeran
Premium
Ratings
Myles Minter Reiterates Buy on Intellia (NTLA), Citing Extended Cash Runway and Strong Phase III Data for Lonvoguran Ziclumeran
10d ago
NTLA
Intellia Therapeutics Prices Public Equity Offering to Fund Pipeline
Premium
Company Announcements
Intellia Therapeutics Prices Public Equity Offering to Fund Pipeline
21d ago
8K
NTLA
Cathie Wood Makes $14M Bet on Alphabet Stock Ahead of Today’s Q1 Earnings, Buys the Dip in CRWV and Trims Bullish Stake
Premium
Market News
Cathie Wood Makes $14M Bet on Alphabet Stock Ahead of Today’s Q1 Earnings, Buys the Dip in CRWV and Trims Bullish Stake
22d ago
BLSH
CRWV
Cathie Wood Offloads Rocket Lab Stock (RKLB) Despite 3% Jump, Buys the Dip in Intellia (NTLA)
Premium
Market News
Cathie Wood Offloads Rocket Lab Stock (RKLB) Despite 3% Jump, Buys the Dip in Intellia (NTLA)
23d ago
ARKG
ARKK
Intellia Reports Positive Phase 3 Results for HAE Gene Therapy
Premium
Company Announcements
Intellia Reports Positive Phase 3 Results for HAE Gene Therapy
24d ago
8K
NTLA
Intellia Therapeutics: Buy Rating Reiterated on Lonvo-z Phase 3 HAELO Upside Potential; $29 Price Target Maintained
Premium
Ratings
Intellia Therapeutics: Buy Rating Reiterated on Lonvo-z Phase 3 HAELO Upside Potential; $29 Price Target Maintained
24d ago
NTLA
Intellia Therapeutics Adopts Fourth Amended and Restated Bylaws
Premium
Company Announcements
Intellia Therapeutics Adopts Fourth Amended and Restated Bylaws
1M ago
8K
NTLA
More NTLA News >

NTLA News on the Web

J.P. Morgan Remains a Sell on Intellia Therapeutics (NTLA)
TipRanks News
Bearish
Cathie Wood trims $3.17M of surging bioscience stock
TheStreet.com
Bullish
Analysts Have Conflicting Sentiments on These Healthcare Companies: Intellia Therapeutics (NTLA), TriSalus Life Sciences (TLSI) and Fractyl Health, Inc. (GUTS)
TipRanks News
Neutral
Intellia Therapeutics price target raised to $17 from $13 at Bernstein
TipRanks News
Neutral
Intellia Therapeutics price target lowered to $25 from $30 at H.C. Wainwright
TipRanks News
Bearish
Wells Fargo Remains a Hold on Intellia Therapeutics (NTLA)
TipRanks News
Bearish
FDA Commissioner Marty Makary resigns
TipRanks News
Neutral
Intellia Therapeutics price target lowered to $19 from $20 at BofA
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
Media Buzz
This Week0 articles
Weekly Average14.75 articles
News Sentiment
This Week19%
Sector Average77%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NTLA’s Media Buzz Sentiment?
Currently, no data Available
What is NTLA’s weekly average amount of articles?
In an average week, 14.75 articles about NTLA are published.
    What is NTLA’s News Sentiment?
    19% of articles about NTLA were positive this week, compared to its sector average of 77%.
      Healthcare Stocks that are Trending in the News
      GOSSGossamer Bio
      RLAYRelay Therapeutics
      ROIVRoivant Sciences
      IMVTImmunovant
      PROKProKidney
      Showing the stocks with the most bullish news sentiment over the past week